New approaches to cancer care in a COVID-19 world

John Butler; Christian Finley; Charles H. Norell; Samantha Harrison; Heather Bryant; Michael P. Achiam; Alon D. Altman; Nancy Baxter; James Bentley; Paul A. Cohen; M. Asif Chaudry; Elijah Dixon; Rhonda Farrell; Scott Fegan; Salila Hashmi; Claus Hogdall; John T. Jenkins; Janice Kwon; Tom Mala; Orla McNally; Neil Merrett; Gregg Nelson; Andy Nordin; Jason Park; Geoff Porter; John Reynolds; Colin Schieman; Tine Schnack; Allan Spigelman; Lars Bo Svendsen; Peter Sykes; Robert Thomas

doi:10.1016/S1470-2045(20)30340-5

New approaches to cancer care in a COVID-19 world

John Butler
, Christian Finley
, Charles H. Norell
, Samantha Harrison
, Heather Bryant
, Michael P. Achiam
, Alon D. Altman
, Nancy Baxter
, James Bentley
, Paul A. Cohen
, M. Asif Chaudry
, Elijah Dixon
, Rhonda Farrell
, Scott Fegan
, Salila Hashmi
, Claus Hogdall
, John T. Jenkins
, Janice Kwon
, Tom Mala
, Orla McNally

Neil Merrett, Gregg Nelson, Andy Nordin, Jason Park, Geoff Porter, John Reynolds, Colin Schieman, Tine Schnack, Allan Spigelman, Lars Bo Svendsen, Peter Sykes, Robert Thomas

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Abstract

The effects of COVID-19 on cancer are substantial, highlighting both novel and existing challenges for health-care systems. We were therefore encouraged to see The Lancet Oncology's call for cancer care to be safeguarded in a postCOVID-19 world.1 We endorse this position for cancer surgery specifically, and propose several recommendations aiming to reduce the so-called collateral damage of COVID-19. The International Cancer Benchmarking Partnership (ICBP) is a global collaboration seeking to compare and improve cancer survival across high income countries.2 Within the ICBP, we came together to provide a voice for the international cancer surgery community.

Original language	English
Pages (from-to)	e339-e340
Number of pages	2
Journal	The Lancet Oncology
Volume	21
Issue number	7
DOIs	https://doi.org/10.1016/S1470-2045(20)30340-5
Publication status	Published - Jul 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

COVID-19 (disease)
cancer
pandemics

Access to Document

10.1016/S1470-2045(20)30340-5

Cite this

Butler, J., Finley, C., Norell, C. H., Harrison, S., Bryant, H., Achiam, M. P., Altman, A. D., Baxter, N., Bentley, J., Cohen, P. A., Chaudry, M. A., Dixon, E., Farrell, R., Fegan, S., Hashmi, S., Hogdall, C., Jenkins, J. T., Kwon, J., Mala, T., ... Thomas, R. (2020). New approaches to cancer care in a COVID-19 world. The Lancet Oncology, 21(7), e339-e340. https://doi.org/10.1016/S1470-2045(20)30340-5

@article{1e5708050f984a4bb463e1830a30daad,

title = "New approaches to cancer care in a COVID-19 world",

abstract = "The effects of COVID-19 on cancer are substantial, highlighting both novel and existing challenges for health-care systems. We were therefore encouraged to see The Lancet Oncology's call for cancer care to be safeguarded in a postCOVID-19 world.1 We endorse this position for cancer surgery specifically, and propose several recommendations aiming to reduce the so-called collateral damage of COVID-19. The International Cancer Benchmarking Partnership (ICBP) is a global collaboration seeking to compare and improve cancer survival across high income countries.2 Within the ICBP, we came together to provide a voice for the international cancer surgery community.",

keywords = "COVID-19 (disease), cancer, pandemics",

author = "John Butler and Christian Finley and Norell, \{Charles H.\} and Samantha Harrison and Heather Bryant and Achiam, \{Michael P.\} and Altman, \{Alon D.\} and Nancy Baxter and James Bentley and Cohen, \{Paul A.\} and Chaudry, \{M. Asif\} and Elijah Dixon and Rhonda Farrell and Scott Fegan and Salila Hashmi and Claus Hogdall and Jenkins, \{John T.\} and Janice Kwon and Tom Mala and Orla McNally and Neil Merrett and Gregg Nelson and Andy Nordin and Jason Park and Geoff Porter and John Reynolds and Colin Schieman and Tine Schnack and Allan Spigelman and Svendsen, \{Lars Bo\} and Peter Sykes and Robert Thomas",

year = "2020",

month = jul,

doi = "10.1016/S1470-2045(20)30340-5",

language = "English",

volume = "21",

pages = "e339--e340",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "7",

}

Butler, J, Finley, C, Norell, CH, Harrison, S, Bryant, H, Achiam, MP, Altman, AD, Baxter, N, Bentley, J, Cohen, PA, Chaudry, MA, Dixon, E, Farrell, R, Fegan, S, Hashmi, S, Hogdall, C, Jenkins, JT, Kwon, J, Mala, T, McNally, O, Merrett, N, Nelson, G, Nordin, A, Park, J, Porter, G, Reynolds, J, Schieman, C, Schnack, T, Spigelman, A, Svendsen, LB, Sykes, P & Thomas, R 2020, 'New approaches to cancer care in a COVID-19 world', The Lancet Oncology, vol. 21, no. 7, pp. e339-e340. https://doi.org/10.1016/S1470-2045(20)30340-5

TY - JOUR

T1 - New approaches to cancer care in a COVID-19 world

AU - Butler, John

AU - Finley, Christian

AU - Norell, Charles H.

AU - Harrison, Samantha

AU - Bryant, Heather

AU - Achiam, Michael P.

AU - Altman, Alon D.

AU - Baxter, Nancy

AU - Bentley, James

AU - Cohen, Paul A.

AU - Chaudry, M. Asif

AU - Dixon, Elijah

AU - Farrell, Rhonda

AU - Fegan, Scott

AU - Hashmi, Salila

AU - Hogdall, Claus

AU - Jenkins, John T.

AU - Kwon, Janice

AU - Mala, Tom

AU - McNally, Orla

AU - Merrett, Neil

AU - Nelson, Gregg

AU - Nordin, Andy

AU - Park, Jason

AU - Porter, Geoff

AU - Reynolds, John

AU - Schieman, Colin

AU - Schnack, Tine

AU - Spigelman, Allan

AU - Svendsen, Lars Bo

AU - Sykes, Peter

AU - Thomas, Robert

PY - 2020/7

Y1 - 2020/7

N2 - The effects of COVID-19 on cancer are substantial, highlighting both novel and existing challenges for health-care systems. We were therefore encouraged to see The Lancet Oncology's call for cancer care to be safeguarded in a postCOVID-19 world.1 We endorse this position for cancer surgery specifically, and propose several recommendations aiming to reduce the so-called collateral damage of COVID-19. The International Cancer Benchmarking Partnership (ICBP) is a global collaboration seeking to compare and improve cancer survival across high income countries.2 Within the ICBP, we came together to provide a voice for the international cancer surgery community.

AB - The effects of COVID-19 on cancer are substantial, highlighting both novel and existing challenges for health-care systems. We were therefore encouraged to see The Lancet Oncology's call for cancer care to be safeguarded in a postCOVID-19 world.1 We endorse this position for cancer surgery specifically, and propose several recommendations aiming to reduce the so-called collateral damage of COVID-19. The International Cancer Benchmarking Partnership (ICBP) is a global collaboration seeking to compare and improve cancer survival across high income countries.2 Within the ICBP, we came together to provide a voice for the international cancer surgery community.

KW - COVID-19 (disease)

KW - cancer

KW - pandemics

UR - https://hdl.handle.net/1959.7/uws:57846

U2 - 10.1016/S1470-2045(20)30340-5

DO - 10.1016/S1470-2045(20)30340-5

M3 - Article

C2 - 32615112

SN - 1470-2045

VL - 21

SP - e339-e340

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 7

ER -

New approaches to cancer care in a COVID-19 world

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this